November 18, 2026
Health news, explained with evidence
LIVE

Researchers Compare Methods for Evaluating Inhaler Technique in Respiratory Patients

🔬 Research 1 min read 👁 1

A new study evaluates three different clinical approaches to assessing how patients with asthma and COPD use their inhalers, finding significant differences in how these methods perform.

🔬Research

Key points

  • Three inhaler assessment methods were compared for reliability and utility.
  • The 4-level scale was found to be the most practical and least time-consuming.
  • Assessment methods showed low agreement, meaning they are not interchangeable.

Researchers from Warsaw Medical University have investigated the effectiveness of three distinct methods for evaluating inhalation technique among patients with asthma and chronic obstructive pulmonary disease (COPD). The study, published in npj Primary Care Respiratory Medicine, compared an inhalation error checklist, a 4-level rating scale, and the Vitalograph® AIM device to determine which tools provide the most reliable and practical assessment for clinical use.

The study involved 121 participants and found that while the error checklist and the 4-level scale demonstrated moderate to good reliability, their results did not align well with the objective data provided by the Vitalograph® AIM. Furthermore, the researchers noted that the three methods showed low concordance with one another, suggesting that they cannot be used interchangeably in a clinical setting.

What to know: The 4-level scale was identified as the most time-efficient and user-friendly option for clinicians, whereas the Vitalograph® AIM offered more objective measurements but required more time and complexity. Because these tools measure technique differently, patients should consult their healthcare providers to determine the most appropriate method for their specific device and treatment plan.

Source Nature Health Sciences — nature.com/articles/s41533-026-00581-8 ↗

Contact the newsroom

Got a tip, a proposal or a partnership question? Write to us and we will reply shortly.